Ryan Verma

A Comparison of B Cell-Targeting Treatments for Multiple Sclerosis

Started May 22, 2024

Abstract or project description

Multiple sclerosis (MS) is the most common chronic inflammatory neurodegenerative disease in young adults and a leading cause of nontraumatic neurological disability. The cause of MS is not fully understood, but both genetic and environmental factors are believed to play a role. B cells are an important part of the immune response and have been shown to play a significant role in MS. This paper reviews studies on various B cell-targeting treatments for MS to determine which are the most effective at specific stages of the disease. In the end, all of the treatments that were investigated were found to be effective for treating relapsing-remitting MS, and results varied for primary progressive and secondary progressive MS.